Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

IMPEL NEUROPHARMA, INC.

(IMPL)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su IMPEL NEUROPHARMA, INC.
10/09Health Care Stocks Ail During Friday Trading
10/09Health Care Stocks Ailing Friday
10/09Wall Street Set for Gains as Biden-Xi Call Lifts Sentiment
10/09IMPEL NEUROPHARMA: Prices Offering at $15 Per Share
10/09IMPEL NEUROPHARMA: Announces Pricing of $45.0 Million Public Offering
09/09IMPEL NEUROPHARMA: Shares Rebound Amid Heavy Trading
08/09BORSA DI WALL STREET: Wall Street bogged down by Delta spread
08/09ANALYST RECOMMENDATIONS: Adobe, Broadcom, Chipotle Mexican Grill, Netflix, Voda..
07/09IMPEL NEUROPHARMA: Launches Stock Offering
07/09Impel NeuroPharma Announces Launch of Proposed Public Offering
06/09IMPEL NEUROPHARMA: Announces U.S. FDA Approval of TRUDHESA (Dihydroergotamine M..
03/09IMPEL NEUROPHARMA: Migraine Drug Trudhesa Approved by FDA; Shares Jump
03/09Impel NeuroPharma Gets FDA Approval for Trudhesa Nasal Spray
03/09Impel NeuroPharma Shares Rise 20% After FDA Approval of Migraine Treatment
03/09Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA™ (Dihydroergo..
16/08IMPEL NEUROPHARMA: Q2 Net Loss Widens
16/08IMPEL NEUROPHARMA: Management's Discussion and Analysis of Financial Condition ..
16/08Impel NeuroPharma Announces Second Quarter 2021 Financial Results and Provide..
16/08IMPEL NEUROPHARMA: Earnings Flash (IMPL) IMPEL NEUROPHARMA Posts Q2 EPS $-0.79
16/08Impel NeuroPharma, Inc. Reports Consolidated Earnings Results for the Second ..
16/08IMPEL NEUROPHARMA: Increased Cash Position and Extended Runway through 2022 Fol..
16/08IMPEL NEUROPHARMA INC: Results of Operations and Financial Condition, Financial..
09/08Impel NeuroPharma to Report Second Quarter 2021 Financial Results on Monday, ..
09/08IMPEL NEUROPHARMA: Reports Positive Data From Study of Trudhesa to Treat Migrai..
09/08IMPEL NEUROPHARMA: Announces Publication of Pivotal Phase 3, Open-Label Stop 30..
09/08Impel NeuroPharma Announces Publication of Pivotal Phase 3, Open-Label Stop 3..
04/08Top Premarket Gainers
03/08Impel NeuroPharma to Present at the 2021 Wedbush Pacgrow Virtual Healthcare C..
29/07IMPEL NEUROPHARMA: to Host Virtual Key Opinion Leader Event on August 6, 2021
07/07IMPEL NEUROPHARMA: Secures $50 Million Debt Financing Deal With Oxford Finance,..
07/07Impel NeuroPharma Enters Into a $50 Million Debt Financing Agreement With Oxf..
07/07IMPEL NEUROPHARMA INC: Entry into a Material Definitive Agreement, Creation of ..
07/07Impel Neuropharma, Inc. Enters into Loan and Security Agreement with Oxford F..
21/06IMPEL NEUROPHARMA, INC.(NASDAQGM: IMPL) added to S&P TMI Index
16/06IMPEL NEUROPHARMA: to Present at the Raymond James Human Health Innovation Conf..
07/06Impel NeuroPharma Announces First Quarter 2021 Financial Results and Provides..
07/06Impel NeuroPharma, Inc. Reports Consolidated Earnings Results for the First Q..
07/06IMPEL NEUROPHARMA: Announces First Quarter 2021 Financial Results and Provides ..
07/06IMPEL NEUROPHARMA INC: Results of Operations and Financial Condition, Financial..
07/06IMPEL NEUROPHARMA: Management's Discussion and Analysis of Financial Condition ..
02/06IMPEL NEUROPHARMA: to Present Pivotal, Phase 3 Data From STOP-301 Study at The ..
02/06Impel NeuroPharma, Inc. to Present Pivotal, Phase 3 Data from Stop-301 Study ..
18/05Impel NeuroPharma Launches Reroute Migraine Relief, Educational Initiative Th..
26/04IMPEL NEUROPHARMA, INC.(NASDAQGM: IMPL) added to NASDAQ Composite Index
22/04Impel NeuroPharma, Inc. has completed an IPO in the amount of $80.00001 milli..
02/04Impel NeuroPharma, Inc. has filed an IPO in the amount of $75 million.
02/04Impel NeuroPharma, Inc. Auditor Raises 'Going Concern' Doubt
12/03Impel NeuroPharma, Inc. announced that it has received $7.5 million in fundin..
05/03Impel NeuroPharma, Inc. announced that it expects to receive $7.5 million in ..
01/03Impel Neuropharma Announces Key Management Team Appointments as Company Advan..
20/01Impel Neuropharma Announces U.S. Food & Drug Administration Acceptance of New..
2020Impel NeuroPharma, Inc. Announces FDA Submission Of New Drug Application For ..
2020Impel NeuroPharma Announces Data From Pivotal Phase 3 Registration Study Of I..
2020Impel NeuroPharma Announces Publication of Positive Results of SNAP 101 Study..
2020Impel NeuroPharma Announces Primary Objectives Met in Pivotal Phase 3 Registr..
2020Impel Neuropharma, Inc. Announces Executive Changes
2020Impel Neuropharma Announces Appointment of Adrian Adams as Chairman of the Bo..
2019Impel NeuroPharma, Inc. Announces Appointment of Diane Wilfong to Board of Di..
2019Impel NeuroPharma, Inc. Announces Last Patient Enrolled in Phase 3 Trial Eval..
2019Impel NeuroPharma to Present Data From INP104 Clinical Program at the 61st An..
2019Impel NeuroPharma Appoints Jennifer L. Berman as Vice President of Marketing
2019Impel NeuroPharma Announces Positive Phase 1 Trial for INP105 for the Treatme..
2018Impel NeuroPharma, Inc. Appoints Mittendorff and Satvat as New Members of Imp..
2018Impel NeuroPharma, Inc. announced that it has received $67.5 million in fundi..
2018Impel NeuroPharma Appoints Ellen A. Lubman As Chief Business Officer
2018Impel NeuroPharma Announces First Patient Dosed in Phase 3 Trial Evaluating I..
2018Impel Neuropharma Inc. Appoints Lynn C. Gold as Senior Vice President of Regu..
2018Impel Neuropharma Announces FDA Clearance of Ind for Pivotal Phase 3 Study of..
2018Impel NeuroPharma Announces Initiation of Phase IIa Study of INP103 in Parkin..
2018Impel NeuroPharma Announces Positive Results of Phase 1 Clinical Trial of INP..
2017Impel NeuroPharma, Inc. Appoints Jon Congleton as President and Chief Executi..
2017Impel NeuroPharma Appoints Timothy S. Nelson to its Board of Directors
2016Impel NeuroPharma, Inc. announced that it has received $22.297064 million in ..
2016Impel Neuropharma Inc. announced that it expects to receive funding
2016Impel Neuropharma Inc. announced that it has received $0.08 million in fundin..
1  2Pross.